Neutropenia during HIV Infection: Adverse Consequences and Remedies

REFERENCES

• Rosenberg ZF, Fauci AS. Immunopathogenic mechanisms in human immunodeficiency virus (HIV) infections. Ann NY Acad Sci 1988;546:164–174.
   PubMed Web of Science ®Google Scholar
• Schneider DR, Picker LJ. Myelodysplasia in the acquired immune deficiency syndrome. Am J Clin Pathol 1985;84:144–152.
   PubMed Web of Science ®Google Scholar
• Sloand E. Hematologic complications of HIV infection. AIDS Rev 2005;7:187–196.
   PubMedGoogle Scholar
• Highleyman L. Blood cell deficiencies. BETA 1998;11–17, 22.
   PubMedGoogle Scholar
• Jacobson MA, Liu RC, Davies D, Cohen PT. Human immunodeficiency virus disease related neutropenia and the risk of hospitalization for bacterial infection. Arch Intern Med 1997;157:1825–1831.
   PubMedGoogle Scholar
• Kuritzkes DR. Neutropenia, neutrophil dysfunction, and bacterial infection in patients with human immunodeficiency virus disease: the role of granulocyte colony-stimulating factor. Clin Infect Dis 2000;30:256–260.
   PubMed Web of Science ®Google Scholar
• Manfredi R, Nanetti A, Valentini R, Frequency, epidemiology, risk factors, clinical and bacteriological features of enterococcal disease in patients with HIV infection in a decade survey. New Microbiol 2002;25:179–186.
   Google Scholar
• Hermans P, Sommereijns B, Van Cutsem N, Clumeck N. Neutropenia in patients with HIV infection: a case control study in a cohort of 1403 patients between 1982 and 1993. J Hematother Stem Cell Res 1999;8(Suppl 1):S23–S32.
   Google Scholar
• Gallo RC, Sarin PS, Gelmann EP, Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS). Science 1983;220:865–867.
   PubMed Web of Science ®Google Scholar
• Barré-Sinoussi F, Chermann JC, Rey F, Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983;220: 868–871.
   PubMed Web of Science ®Google Scholar
• Wormser GP, Krupp LB, Hanrahan JP, Acquired immunodeficiency syndrome in male prisoners. New insights into an emerging syndrome. Ann Intern Med 1983;98:297–303.
   PubMed Web of Science ®Google Scholar
• Spivak JL, Selonick SE, Quinn TC. Acquired immune deficiency syndrome and pancytopenia. JAMA 1983;250:3084–3087.
   PubMed Web of Science ®Google Scholar
• Spivak JL, Bender BS, Quinn TC. Hematologic abnormalities in the acquired immune deficiency syndrome. Am J Med 1984;77:224–228.
   Google Scholar
• Gold JW, Weikel CS, Godbold J, Unexplained persistent lymphadenopathy in homosexual men and the acquired immune deficiency syndrome. Medicine (Baltimore) 1985;64:203–213.
   PubMed Web of Science ®Google Scholar
• Zon LI, Arkin C, Groopman JE. Haematologic manifestations of the human immune deficiency virus (HIV). Br J Haematol 1987;66:251–256.
   PubMed Web of Science ®Google Scholar
• Treacy M, Lai L, Costello C, Clark A. Peripheral blood and bone marrow abnormalities in patients with HIV related disease. Br J Haematol 1987;65:289–294.
   PubMed Web of Science ®Google Scholar
• Delacrétaz F, Perey L, Schmidt PM, Histopathology of bone marrow in human immunodeficiency virus infection. Virchows Arch A Pathol Anat Histopathol 1987;411:543–551.
   PubMedGoogle Scholar
• Mir N, Costello C, Luckit J, HIV-disease and bone marrow changes: a study of 60 cases. Eur J Haematol 1989;42:339–343.
   PubMed Web of Science ®Google Scholar
• Sun NC, Shapshak P, Lachant NA, Bone marrow examination in patients with AIDS and AIDS-related complex (ARC). Morphologic and in situ hybridization studies. Am J Clin Pathol 1989;92:589–594.
   PubMed Web of Science ®Google Scholar
• Toure S, Gabillard D, Inwoley A, Incidence of neutropenia in HIV-infected African adults receiving co-trimoxazole prophylaxis: a 6-year cohort study in Abidjan, Cote d'Ivoire. Trans R Soc Trop Med Hyg 2006;100:785–790.
   PubMedGoogle Scholar
• Levine AM, Karim R, Mack W, Neutropenia in human immunodeficiency virus infection: data from the women's interagency HIV study. Arch Intern Med 2006;166:405–410.
   PubMed Web of Science ®Google Scholar
• Murphy MF, Metcalfe P, Waters AH, Incidence and mechanism of neutropenia and thrombocytopenia in patients with human immunodeficiency virus infection. Br J Haematol 1987;66:337–340.
   PubMed Web of Science ®Google Scholar
• Spada C, Treitinger A, Hoshikawa-Fujimura AY. HIV influence on hematopoiesis at the initial stage of infection. Eur J Haematol 1998;61:255–260.
   PubMedGoogle Scholar
• Ortega M, Almela M, Soriano A, Bloodstream infections among human immunodeficiency virus-infected adult patients: epidemiology and risk factors for mortality. Eur J Clin Microbiol Infect Dis 2008;27:969–976.
   PubMed Web of Science ®Google Scholar
• Dobmeyer TS, Raffel B, Dobmeyer JM, Decreased function of monocytes and granulocytes during HIV-1 infection correlates with CD4 cell counts. Eur J Med Res 1995;1:9–15.
   PubMedGoogle Scholar
• Moore DA, Sullivan A, Hilstead P, A retrospective study of neutropenia in HIV disease. Int J STD AIDS 2000;11:8–14.
   PubMedGoogle Scholar
• Colson P, Foucault C, Mokhtari M, et al. Severe transient neutropenia associated with acute human immunodeficiency virus type 1 infection. Eur J Intern Med 2005;16:120–122.
   PubMedGoogle Scholar
• Skiest DJ, King ME. Granulocytopenia secondary to acute infection with the human immunodeficiency virus. J Infect 1994;28:315–318.
   PubMedGoogle Scholar
• Meira DG, Lorand-Metze I, Toro AD, Bone marrow features in children with HIV infection and peripheral blood cytopenias. J Trop Pediatr 2005;51:114–119.
   PubMedGoogle Scholar
• Calenda V, Chermann JC. The effects of HIV on hematopoiesis. Eur J Haematol 1992;48:181–186.
   PubMedGoogle Scholar
• Danova M, Riccardi A, Brugnatelli S, Bone marrow morphology and proliferative activity in acquired immunodeficiency syndrome. Haematologica 1989;74:365–369.
   PubMedGoogle Scholar
• Katsarou O, Terpos E, Patsouris E, Myelodysplastic features in patients with long-term HIV infection and haemophilia. Haemophilia 2001;7:47–52.
   Google Scholar
• Ryu T, Ikeda M, Okazaki Y, Myelodysplasia associated with acquired immunodeficiency syndrome. Intern Med 2001;40:795–801.
   Google Scholar
• Shalekoff S, Tiemessen CT, Gray CM, Depressed phagocytosis and oxidative burst in polymorphonuclear leukocytes from individuals with pulmonary tuberculosis with or without human immunodeficiency virus type 1 infection. Clin Diagn Lab Immunol 1998;5:41–44.
   PubMedGoogle Scholar
• Murphy PM, Lane HC, Fauci AS, Impairment of neutrophil bactericidal capacity in patients with AIDS. J Infect Dis 1988;158:627–630.
   PubMedGoogle Scholar
• Elbim C, Prevot MH, Bouscarat F, Polymorphonuclear neutrophils from human immunodeficiency virus-infected patients show enhanced activation, diminished fMLP-induced L-selectin shedding, and an impaired oxidative burst after cytokine priming. Blood 1994;84:2759–2766.
   PubMedGoogle Scholar
• Pitrak DL, Bak PM, DeMarais P, Depressed neutrophil superoxide production in human immunodeficiency virus infection. J Infect Dis 1993;167:1406–1410.
   Google Scholar
• Moore RD, Keruly JC, Chaisson RE. Neutropenia and bacterial infection in acquired immunodeficiency syndrome. Arch Intern Med 1995;155:1965–1970.
   PubMedGoogle Scholar
• Moore DA, Benepal T, Portsmouth S, Etiology and natural history of neutropenia in human immunodeficiency virus disease: a prospective study. Clin Infect Dis 2001;32:469–475.
   PubMedGoogle Scholar
• Tumbarello M, Tacconelli E, Donati KG, HIV-associated bacteremia: how it has changed in the highly active antiretroviral therapy (HAART) era. J Acquir Immune Defic Syndr 2000;23:145–151.
   PubMed Web of Science ®Google Scholar
• Tumbarello M, Tacconelli E, Caponera S, The impact of bacteraemia on HIV infection. Nine years experience in a large Italian university hospital. J Infect 1995;31:123–131.
   PubMedGoogle Scholar
• Meyer CN, Skinhøj P, Prag J. Bacteremia in HIV-positive and AIDS patients: incidence, species distribution, risk-factors, outcome, and influence of long-term prophylactic antibiotic treatment. Scand J Infect Dis 1994;26:635–642.
   PubMed Web of Science ®Google Scholar
• Keiser P, Higgs E, Smith J. Neutropenia is associated with bacteremia in patients infected with the human immunodeficiency virus. Am J Med Sci 1996;312:118–122.
   PubMedGoogle Scholar
• Keiser P, Rademacher S, Smith JW, Granulocyte colony-stimulating factor use is associated with decreased bacteremia and increased survival in neutropenic HIV-infected patients. Am J Med 1998;104:48–55.
   PubMedGoogle Scholar
• Saitoh T, Komano J, Saitoh Y, Neutrophil extracellular traps mediate a host defense response to human immunodeficiency virus-1. Cell Host Microbe 2012;12:109–116.
   PubMed Web of Science ®Google Scholar
• Moh R, Danel C, Sorho S, Haematological changes in adults receiving a zidovudine-containing HAART regimen in combination with cotrimoxazole in Côte d'Ivoire. Antivir Ther 2005;10:615–624.
   PubMed Web of Science ®Google Scholar
• McNamara LA, Collins KL. Hematopoietic stem/precursor cells as HIV reservoirs. Curr Opin HIV AIDS 2011;6:43–48.
   PubMed Web of Science ®Google Scholar
• Re MC, Furlini G, Zauli G, Human immunodeficiency virus type 1 (HIV-1) and human hematopoietic progenitor cells. Arch Virol 1994;137:1–23.
   PubMed Web of Science ®Google Scholar
• Kitano K, Abboud CN, Ryan DH, Macrophage-active colony-stimulating factors enhance human immunodeficiency virus type 1 infection in bone marrow stem cells. Blood 1991;77:1699–1705.
   PubMed Web of Science ®Google Scholar
• Mir KD, Mavigner M, Silvestri G. et al. The myeloid cytokine network in AIDS pathogenesis. Cytokine Growth Factor Rev 2012;23:223–231.
   PubMedGoogle Scholar
• Civin CI, Gore SD. Antigenic analysis of hematopoiesis: a review. J Hematother 1993;2:137–144.
   PubMedGoogle Scholar
• Zauli G, Furlini G, Vitale M, A subset of human CD34+ hematopoietic progenitors express low levels of CD4, the high-affinity receptor for human immunodeficiency virus-type 1. Blood 1994;84:1896–1905.
   PubMed Web of Science ®Google Scholar
• Aiuti A, Turchetto L, Cota M, Human CD34(+) cells express CXCR4 and its ligand stromal cell-derived factor-1. Implications for infection by T-cell tropic human immunodeficiency virus. Blood 1999;94:62–73.
   PubMed Web of Science ®Google Scholar
• Lee B, Ratajczak J, Doms RW, Coreceptor/chemokine receptor expression on human hematopoietic cells: biological implications for human immunodeficiency virus-type 1 infection. Blood 1999;93:1145–1156.
   PubMed Web of Science ®Google Scholar
• Deichmann M, Kronenwett R, Haas R. Expression of the human immunodeficiency virus type-1 coreceptors CXCR-4 (fusin, LESTR) and CKR-5 in CD34+ hematopoietic progenitor cells. Blood 1997;89:3522–3528.
   PubMed Web of Science ®Google Scholar
• Alexaki A, Wigdahl B. HIV-1 infection of bone marrow hematopoietic progenitor cells and their role in trafficking and viral dissemination. PLoS Pathog 2008;4:1–9.
   Google Scholar
• Stutte HJ, Müller H, Falk S, Pathophysiological mechanisms of HIV-induced defects in haematopoiesis: pathology of the bone marrow. Res Virol 1990;141:195–200.
   PubMedGoogle Scholar
• Redd AD, Avalos A, Essex M. Infection of hematopoietic progenitor cells by HIV-1 subtype C, and its association with anemia in southern Africa. Blood 2007;110:3143–3149.
   PubMedGoogle Scholar
• Carter CC, Onafuwa-Nuga A, McNamara LA, HIV-1 infects multipotent progenitor cells causing cell death and establishing latent cellular reservoirs. Nat Med 2010;16:446–451.
   PubMed Web of Science ®Google Scholar
• Davis BR, Zauli G. Effect of human immunodeficiency virus infection on haematopoiesis. Baillieres Clin Haematol 1995;8:113–130.
   PubMed Web of Science ®Google Scholar
• Zauli G, Vitale M, Gibellini D, Inhibition of purified CD34+ hematopoietic progenitor cells by human immunodeficiency virus 1 or gp120 mediated by endogenous transforming growth factor beta 1. J Exp Med 1996;183:99–108.
   PubMed Web of Science ®Google Scholar
• Banda NK, Tomczak JA, Shpall EJ, HIV-gp120 induced cell death in hematopoietic progenitor CD34+ cells. Apoptosis 1997;2:61–68.
   PubMedGoogle Scholar
• Calenda V, Graber P, Delamarter JF, Involvement of HIV nef protein in abnormal hematopoiesis in AIDS: in vitro study on bone marrow progenitor cells. Eur J Haematol 1994;52:103–107.
   PubMed Web of Science ®Google Scholar
• Prost S, Le Dantec M, Auge S, Human and simian immunodeficiency viruses deregulate early hematopoiesis through a Nef/PPARgamma/STAT5 signaling pathway in macaques. J Clin Invest 2008;118:1765–1775.
   PubMedGoogle Scholar
• Rameshwar P, Denny TN, Gascon P. Enhanced HIV-1 activity in bone marrow can lead to myelopoietic suppression partially contributed by gag p24. J Immunol 1996;157:4244–4250.
   PubMed Web of Science ®Google Scholar
• Prakash O, Zhang P, Xie M, The human immunodeficiency virus type I Tat protein potentiates ethanol-induced neutrophil functional impairment in transgenic mice. Alcohol Clin Exp Res 1998;22:2043–2049.
   PubMedGoogle Scholar
• Bucur SZ, Gillespie TW, Lee ME, Hematopoietic response to lineage-non-specific (rrIL-3) and lineage-specific (rhG-CSF, rhEpo, rhTpo) cytokine administration in SIV-infected rhesus macaques is related to stage of infection. J Med Primatol 2000;29:47–56.
   PubMedGoogle Scholar
• Baillou C, Simon A, Leclercq V, Highly active antiretroviral therapy corrects hematopoiesis in HIV-1 infected patients: interest for peripheral blood stem cell-based gene therapy. AIDS 2003;17:563–574.
   PubMedGoogle Scholar
• Hillyer CD, Lackey DA, 3rd, Villinger F, CD34+ and CFU-GM progenitors are significantly decreased in SIVsmm9 infected rhesus macaques with minimal evidence of direct viral infection by polymerase chain reaction. Am J Hematol 1993;43:274–278.
   PubMed Web of Science ®Google Scholar
• Thiebot H, Vaslin B, Derdouch S, Impact of bone marrow hematopoiesis failure on T-cell generation during pathogenic simian immunodeficiency virus infection in macaques. Blood 2005;105:2403–2409.
   PubMedGoogle Scholar
• Marandin A, Katz A, Oksenhendler E, Loss of primitive hematopoietic progenitors in patients with human immunodeficiency virus infection. Blood 1996;88:4568–4578.
   PubMed Web of Science ®Google Scholar
• Sloand EM, Young NS, Sato T, Secondary colony formation after long-term bone marrow culture using peripheral blood and bone marrow of HIV-infected patients. AIDS 1997;11:1547–1553.
   PubMed Web of Science ®Google Scholar
• Re MC, Zauli G, Furlini G, The impaired number of circulating granulocyte/macrophage progenitors (CFU-GM) in human immunodeficiency virus-type 1 infected subjects correlates with an active HIV-1 replication. Arch Virol 1993;129:53–64.
   PubMedGoogle Scholar
• Isgrò A, Leti W, De Santis W, Altered clonogenic capability and stromal cell function characterize bone marrow of HIV-infected subjects with low CD4+ T cell counts despite viral suppression during HAART. Clin Infect Dis 2008;46:1902–1910.
   PubMed Web of Science ®Google Scholar
• Hillyer CD, Lackey DA 3rd, Villinger F, CD34+ and CFU-GM progenitors are significantly decreased in SIVsmm9 infected rhesus macaques with minimal evidence of direct viral infection by polymerase chain reaction. Am J Hematol 1993;43:274–278.
   PubMed Web of Science ®Google Scholar
• Schooley RT, Mladenovic J, Sevin A, Reduced mobilization of CD34+ stem cells in advanced human immunodeficiency virus type 1 disease. J Infect Dis 2000;181:148–157.
   PubMed Web of Science ®Google Scholar
• Shen Y, Nilsson SK. Bone, microenvironment and hematopoiesis. Curr Opin Hematol 2012;19:250–255.
   PubMed Web of Science ®Google Scholar
• Wasnik S, Tiwari A, Kirkland MA, Osteohematopoietic stem cell niches in bone marrow. Int Rev Cell Mol Biol 2012;298:95–133.
   PubMedGoogle Scholar
• Carlesso N, Cardoso AA. Stem cell regulatory niches and their role in normal and malignant hematopoiesis. Curr Opin Hematol 2010;17:281–286.
   PubMed Web of Science ®Google Scholar
• Isgrò A, Aiuti A, Leti W, Immunodysregulation of HIV disease at bone marrow level. Autoimmun Rev 2005;4:486–490.
   PubMedGoogle Scholar
• Isgrò A, Aiuti A, Mezzaroma I, Improvement of interleukin 2 production, clonogenic capability and restoration of stromal cell function in human immunodeficiency virus-type-1 patients after highly active antiretroviral therapy. Br J Haematol 2002;118:864–874.
   PubMedGoogle Scholar
• Scadden DT, Zeira M, Woon A, Human immunodeficiency virus infection of human bone marrow stromal fibroblasts. Blood 1990;76:317–322.
   PubMed Web of Science ®Google Scholar
• Parikh N, Nonnemacher MR, Pirrone V, Substance abuse, HIV-1 and hepatitis. Curr HIV Res 2012;10:557–571.
   PubMed Web of Science ®Google Scholar
• Wang L, Mondal D, La Russa VF, Suppression of clonogenic potential of human bone marrow mesenchymal stem cells by HIV type 1: putative role of HIV type 1 tat protein and inflammatory cytokines. AIDS Res Hum Retroviruses 2002;18:917–931.
   PubMedGoogle Scholar
• Moses AV, Williams S, Heneveld ML, Human immunodeficiency virus infection of bone marrow endothelium reduces induction of stromal hematopoietic growth factors. Blood 1996;87:919–925.
   PubMed Web of Science ®Google Scholar
• Mondy K, Tebas P. Emerging bone problems in patients infected with human immunodeficiency virus. Clin Infect Dis 2003;36:S101–S105.
   PubMedGoogle Scholar
• Mondy K, Yarasheski K, Powderly WG, Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals. Clin Infect Dis 2003;36:482–490.
   PubMed Web of Science ®Google Scholar
• De Crignis E, Cimatti L, Borderi M, Bone alterations during HIV infection. New Microbiol 2008;31:155–164.
   PubMedGoogle Scholar
• Gibellini D, De Crignis E, Ponti C, HIV-1 triggers apoptosis in primary osteoblasts and HOBIT cells through TNFalpha activation. J Med Virol 2008;80:1507–1514.
   PubMed Web of Science ®Google Scholar
• Butler JS, Dunning EC, Murray DW, HIV-1 protein induced modulation of primary human osteoblast differentiation and function via a Wnt/β-catenin-dependent mechanism. J Orthop Res 2013;31:218–226.
   PubMedGoogle Scholar
• Nacher M, Serrano S, González A, Osteoblasts in HIV-infected patients: HIV-1 infection and cell function. AIDS 2001;15:2239–2243.
   PubMed Web of Science ®Google Scholar
• Gill V, Shattock RJ, Freeman AR, Macrophages are the major target cell for HIV infection in long-term marrow culture and demonstrate dual susceptibility to lymphocytotropic and monocytotropic strains of HIV-1. Br J Haematol 1996;93:30–37.
   PubMed Web of Science ®Google Scholar
• Canque B, Marandin A, Rosenzwajg M, Susceptibility of human bone marrow stromal cells to human immunodeficiency virus (HIV). Virology 1995;208:779–783.
   PubMed Web of Science ®Google Scholar
• Chelucci C, Federico M, Guerriero R, Productive human immunodeficiency virus-1 infection of purified megakaryocytic progenitors/precursors and maturing megakaryocytes. Blood 1998;91:1225–1234.
   PubMed Web of Science ®Google Scholar
• Dexter TM, Allen TD, Lajtha LG. Conditions controlling the proliferation of haemopoietic stem cells in vitro. J Cell Physiol 1977;91:335–344.
   PubMed Web of Science ®Google Scholar
• Quesenberry P, Song Z, Alberico T, Bone marrow adherent cell hemopoietic growth factor production. Prog Clin Biol Res 1985;184:247–256.
   PubMedGoogle Scholar
• Schwartz GN, Kessler SW, Rothwell SW, Inhibitory effects of HIV-1-infected stromal cell layers on the production of myeloid progenitor cells in human long-term bone marrow cultures. Exp Hematol 1994;22:1288–1296.
   PubMed Web of Science ®Google Scholar
• Bahner I, Kearns K, Coutinho S, Infection of human marrow stroma by human immunodeficiency virus-1 (HIV-1) is both required and sufficient for HIV-1-induced hematopoietic suppression in vitro: demonstration by gene modification of primary human stroma. Blood 1997;90:1787–1798.
   PubMed Web of Science ®Google Scholar
• Zauli G, Davis BR, Re MC, tat protein stimulates production of transforming growth factor-beta 1 by marrow macrophages: a potential mechanism for human immunodeficiency virus-1-induced hematopoietic suppression. Blood 1992;80:3036–3043.
   PubMed Web of Science ®Google Scholar
• Kedzierska K, Crowe SM. Cytokines and HIV-1: interactions and clinical implications. Antivir Chem Chemother 2001;12:133–150.
   PubMedGoogle Scholar
• Keating SM, Golub ET, Nowicki M, The effect of HIV infection and HAART on inflammatory biomarkers in a population-based cohort of women. AIDS 2011;25:1823–1832.
   PubMedGoogle Scholar
• Alonso K, Pontiggia P, Medenica R, Cytokine patterns in adults with AIDS. Immunol Invest 1997;26:341–350.
   PubMed Web of Science ®Google Scholar
• Müller P, Engelstädter M, Werner A, Increased serum and mRNA levels of RANTES associated with elevated levels of activated CD8+CD38+ T cells in HIV-1 infected individuals. Intervirology 1997;40:263–270.
   PubMedGoogle Scholar
• Polo S, Veglia F, Malnati MS, Longitudinal analysis of serum chemokine levels in the course of HIV-1 infection. AIDS 1999;13:447–454.
   PubMed Web of Science ®Google Scholar
• Mayani H, Little MT, Dragowska W, Differential effects of the hematopoietic inhibitors MIP-1 alpha, TGF-beta, and TNF-alpha on cytokine-induced proliferation of subpopulations of CD34+ cells purified from cord blood and fetal liver. Exp Hematol 1995;23:422–427.
   PubMed Web of Science ®Google Scholar
• Geissler RG, Ottmann OG, Eder M, Effect of recombinant human transforming growth factor beta and tumor necrosis factor alpha on bone marrow progenitor cells of HIV-infected persons. Ann Hematol 1991;62:151–155.
   PubMed Web of Science ®Google Scholar
• Scadden DT, Wang A, Zsebo KM, In vitro effects of stem-cell factor or interleukin-3 on myelosuppression associated with AIDS. AIDS 1994;8:193–196.
   PubMedGoogle Scholar
• Broxmeyer HE, Williams DE, Lu L, Cooper S, The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma. J Immunol 1986;136:4487–4495.
   PubMed Web of Science ®Google Scholar
• Re MC, Zauli G, Furlini G, Progressive and selective impairment of IL-3 and IL-4 production by peripheral blood CD4+ T-lymphocytes during the course of HIV-1 infection. Viral Immunol 1992;5:185–194.
   PubMedGoogle Scholar
• Manegold C, Jablonowski H, Armbrecht C, Serum levels of stem cell factor are increased in asymptomatic human immunodeficiency virus-infected patients and are associated with prolonged survival. Blood 1995;86:243–249.
   PubMedGoogle Scholar
• Cebon J, Layton JE, Maher D, Endogenous haemopoietic growth factors in neutropenia and infection. Br J Haematol 1994;86:265–274.
   PubMed Web of Science ®Google Scholar
• Mauss S, Steinmetz HT, Willers R, Induction of granulocyte colony-stimulating factor by acute febrile infection but not by neutropenia in HIV-seropositive individuals. J Acquir Immune Defic Syndr Hum Retrovirol 1997;14:430–434.
   PubMedGoogle Scholar
• Herold M, Meise U, Günther V, Serum concentrations of circulating endogenous granulocyte-macrophage colony-stimulating factor in HIV-1-seropositive injecting drug users. Presse Med 1994;23:1854–1858.
   PubMedGoogle Scholar
• Re MC, Zauli G, Furlini G, GM-CSF production by CD4+ T-lymphocytes is selectively impaired during the course of HIV-1 infection. A possible indication of a preferential lesion of a specific subset of peripheral blood CD4 +T-lymphocytes. Microbiologica 1992;15:265–270.
   PubMedGoogle Scholar
• Bagnara GP, Zauli G, Re MC, Impaired GM-CSF production by cultured light density mononuclear cells and T lymphocytes correlates with the number of circulating CFU-gm in HIV-1 seropositive subjects. Int J Cell Cloning 1991;9:239–250.
   PubMedGoogle Scholar
• Koh PS, Keeble WW, Faulkner GR, Influence of HIV-1 on induced expression of granulopoietic factors: The role of HIV-1 vpr. Exp Hematol 2000;28:S52.
   Google Scholar
• Rubinstein DB, Farrington GK, O'Donnell C, Autoantibodies to leukocyte alphaMbeta2 integrin glycoproteins in HIV infection. Clin Immunol 1999;90:352–359.
   PubMedGoogle Scholar
• Ribera E, Ocaña I, Almirante B, Autoimmune neutropenia and thrombocytopenia associated with development of antibodies to human immunodeficiency virus. J Infect 1989;18:167–170.
   PubMed Web of Science ®Google Scholar
• Savige JA, Chang L, Horn S, Anti-nuclear, anti-neutrophil cytoplasmic and anti-glomerular basement membrane antibodies in HIV-infected individuals. Autoimmunity 1994;18:205–211.
   PubMed Web of Science ®Google Scholar
• Savige JA, Chang L, Crowe SM. Anti-neutrophil cytoplasm antibodies in HIV infection. Adv Exp Med Biol 1993;336:349–352.
   PubMedGoogle Scholar
• Jaresko GS. Etiology of neutropenia in HIV-infected patients. Am J Health Syst Pharm 1999;56 (Suppl 5):S5–S8.
   Google Scholar
• Ownby KK. Management of the hematological manifestations of HIV infection and AIDS. J Assoc Nurses AIDS Care 1995;6:9–15.
   PubMedGoogle Scholar
• Volberding PA, Baker KR, Levine AM. Human immunodeficiency virus hematology. Hematology Am Soc Hematol Educ Program 2003;294–313.
   PubMedGoogle Scholar
• Hakawi AM, Alrajhi AA. Tuberculosis of the bone marrow: clinico-pathological study of 22 cases from Saudi Arabia. Int J Tuberc Lung Dis 2006;10:1041–1044.
   PubMed Web of Science ®Google Scholar
• Khandekar MM, Deshmukh SD, Holla VV, Profile of bone marrow examination in HIV/AIDS patients to detect opportunistic infections, especially tuberculosis. Indian J Pathol Microbiol 2005;48:7–12.
   PubMedGoogle Scholar
• Castella A, Croxson TS, Mildvan D, The bone marrow in AIDS. A histologic, hematologic, and microbiologic study. Am J Clin Pathol 1985;84:425–432.
   PubMed Web of Science ®Google Scholar
• Harris CE, Biggs JC, Concannon AJ, Peripheral blood and bone marrow findings in patients with acquired immune deficiency syndrome. Pathology 1990;22:206–211.
   PubMed Web of Science ®Google Scholar
• Akpek G, Lee SM, Gagnon DR, Bone marrow aspiration, biopsy, and culture in the evaluation of HIV-infected patients for invasive mycobacteria and histoplasma infections. Am J Hematol 2001;67:100–106.
   PubMed Web of Science ®Google Scholar
• Talbot EA, Reller LB, Frothingham R. Bone marrow cultures for the diagnosis of mycobacterial and fungal infections in patients infected with the human immunodeficiency virus. Int J Tuberc Lung Dis 1999;3:908–912.
   PubMed Web of Science ®Google Scholar
• Clark RA, Blakley SL, Greer D, Hematogenous dissemination of Mycobacterium tuberculosis in patients with AIDS. Rev Infect Dis 1991;13:1089–1092.
   PubMedGoogle Scholar
• Calore EE, Tanaka PY, Perez NM, Bone marrow pathology in AIDS. Pathol Res Pract 2004;200:591–597.
   PubMedGoogle Scholar
• Pantanowitz L, Omar T, Sonnendecker H, Bone marrow cryptococcal infection in the acquired immunodeficiency syndrome. J Infect 2000;41:92–94.
   PubMedGoogle Scholar
• Wilkison M, Gauss K, Ran Y, Type 1 interferons suppress accelerated osteoclastogenesis and prevent loss of bone mass during systemic inflammatory responses to Pneumocystis lung infection. Am J Pathol 2012;181:151–162.
   PubMedGoogle Scholar
• Meissner N, Rutkowski M, Harmsen AL, Type I interferon signaling and B cells maintain hemopoiesis during Pneumocystis infection of the lung. J Immunol 2007;178:6604–6615.
   PubMedGoogle Scholar
• Stewart JA, Reef SE, Pellett PE, Herpesvirus infections in persons infected with human immunodeficiency virus. Clin Infect Dis 1995;21:S114–S120.
   PubMed Web of Science ®Google Scholar
• Burke M, Yust I, Katlama C, Cytomegalovirus retinitis in patients with AIDS in Europe. AIDS in Europe Study Group. Eur J Clin Microbiol Infect Dis 1997;16:876–882.
   PubMed Web of Science ®Google Scholar
• Tantawy AA, Sallam TH, Ibrahim DM, Pathogenesis and prognosis of neutropenia in infants and children admitted in a university children hospital in Egypt. Pediatr Hematol Oncol 2013;30:51–59.
   PubMed Web of Science ®Google Scholar
• Sheen JM, Kuo HC, Yu HR, Prolonged acquired neutropenia in children. Pediatr Blood Cancer 2009;53:1284–1288.
   PubMed Web of Science ®Google Scholar
• Sing GK, Ruscetti FW. The role of human cytomegalovirus in haematological diseases. Baillieres Clin Haematol 1995;8:149–163.
   Google Scholar
• Sindre H, Tjøonnfjord GE, Rollag H, Human cytomegalovirus suppression of and latency in early hematopoietic progenitor cells. Blood 1996;88:4526–4533.
   Google Scholar
• Holberg-Petersen M, Rollag H, Beck S, Direct growth suppression of myeloid bone marrow progenitor cells but not cord blood progenitors by human cytomegalovirus in vitro. Blood 1996;88:2510–2516.
   PubMedGoogle Scholar
• Khaiboullina SF, Maciejewski JP, Crapnell K, Human cytomegalovirus persists in myeloid progenitors and is passed to the myeloid progeny in a latent form. Br J Haematol 2004;126:410–417.
   PubMed Web of Science ®Google Scholar
• Zhuravskaya T, Maciejewski JP, Netski DM, Spread of human cytomegalovirus (HCMV) after infection of human hematopoietic progenitor cells: model of HCMV latency. Blood 1997;90:2482–2491.
   PubMedGoogle Scholar
• Zeldis JB, Mugishima H, Steinberg HN, In vitro hepatitis B virus infection of human bone marrow cells. J Clin Invest 1986;78:411–417.
   PubMed Web of Science ®Google Scholar
• Chai T, Prior S, Cooksley WG, Infection of human bone marrow stromal cells by hepatitis B virus: implications for viral persistence and the suppression of hematopoiesis. J Infect Dis 1994;169:871–874.
   PubMed Web of Science ®Google Scholar
• Hoar DI, Bowen T, Matheson D, Hepatitis B virus DNA is enriched in polymorphonuclear leukocytes. Blood 1985;66:1251–1253.
   PubMedGoogle Scholar
• Brook MG, Ayles H, Harrison C, Diagnostic utility of bone marrow sampling in HIV positive patients. Genitourin Med 1997;73:117–121.
   PubMedGoogle Scholar
• Hua Y, Vickers TA, Baker BF, Enhancement of SMN2 exon 7 inclusion by antisense oligonucleotides targeting the exon. PLoS Biol 2007;5:729–744.
   Web of Science ®Google Scholar
• Brouland JP, Audouin J, Hofman P, Bone marrow involvement by disseminated toxoplasmosis in acquired immunodeficiency syndrome: the value of bone marrow trephine biopsy and immunohistochemistry for the diagnosis. Hum Pathol 1996;27:302–306.
   PubMed Web of Science ®Google Scholar
• Garzia M, Damiano F, Melioli G, Morphological diagnosis by bone marrow aspirate of toxoplasmosis infection in an HIV-positive patient. Lab Hematol 2007;13:27–29.
   PubMedGoogle Scholar
• Jacobs JL, Gold JW, Murray HW, Salmonella infections in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1985;102:186–188.
   PubMed Web of Science ®Google Scholar
• Puthucheary SD, Ng KP, Hafeez A, Salmonellosis in persons infected with human immunodeficiency virus: a report of seven cases from Malaysia. Southeast Asian J Trop Med Public Health 2004;35:361–365.
   PubMedGoogle Scholar
• Casado JL, Navas E, Frutos B, Salmonella lung involvement in patients with HIV infection. Chest 1997;112:1197–1201.
   PubMed Web of Science ®Google Scholar
• Wain J, Pham VB, Ha V, Quantitation of bacteria in bone marrow from patients with typhoid fever: relationship between counts and clinical features. J Clin Microbiol 2001;39:1571–1576.
   PubMed Web of Science ®Google Scholar
• Mathew A, Raviglione MC, Splenectomy in patients with AIDS. Am J Hematol 1989;32:184–189.
   PubMedGoogle Scholar
• Archibald LK, McDonald LC, Rheanpumikankit S, Fever and human immunodeficiency virus infection as sentinels for emerging mycobacterial and fungal bloodstream infections in hospitalized patients >/ = 15 years old, Bangkok. J Infect Dis 1999;180:87–92.
   PubMed Web of Science ®Google Scholar
• Gagne SS. Toxoplasmosis. Prim Care Update Ob Gyns 2001;8:122–126.
   PubMedGoogle Scholar
• Pantanowitz L, Dezube BJ. Editorial comment: hemophagocytic syndrome–an HIV-associated quagmire. AIDS Read 2007;17:500–502.
   PubMedGoogle Scholar
• Castilletti C, Preziosi R, Bernardini G, Hemophagocytic syndrome in a patient with acute human immunodeficiency virus infection. Clin Infect Dis 2004;38:1792–1793.
   PubMedGoogle Scholar
• Chen TL, Wong WW, Chiou TJ. Hemophagocytic syndrome: an unusual manifestation of acute human immunodeficiency virus infection. Int J Hematol 2003;78:450–452.
   PubMedGoogle Scholar
• Sproat LO, Pantanowitz L, Lu CM, Human immunodeficiency virus-associated hemophagocytosis with iron-deficiency anemia and massive splenomegaly. Clin Infect Dis 2003;37:e170–e173.
   PubMed Web of Science ®Google Scholar
• Khagi S, Danilova O, Rauwerdink C. Hemophagocytic syndrome in a patient with human immunodeficiency virus, Epstein-Barr viremia, and newly diagnosed Hodgkin lymphoma. Clin Adv Hematol Oncol 2012;10:260–262.
   PubMedGoogle Scholar
• Thoden J, Rieg S, Venhoff N, Fatal hemophagocytic syndrome in a patient with a previously well-controlled asymptomatic HIV infection after EBV reactivation. J Infect 2012;64:110–112.
   PubMedGoogle Scholar
• Kim B, Jeon YK, Kim CW. Kaposi sarcoma herpes virus-associated hemophagocytic syndrome complicated by multicentric castleman disease and kaposi sarcoma in a HIV-negative immunocompetent patient: an autopsy case. J Korean Med Sci 2009;24:970–974.
   PubMed Web of Science ®Google Scholar
• De Lavaissière M, Manceron V, Bourée P, Reconstitution inflammatory syndrome related to histoplasmosis, with a hemophagocytic syndrome in HIV infection. J Infect 2009;58:245–247.
   PubMedGoogle Scholar
• Wong CK, Wong BC, Chan KC, Cytokine profile in fatal human immunodeficiency virus tuberculosis Epstein-Barr virus associated hemophagocytic syndrome. Arch Intern Med 2007;167:1901–1903.
   PubMedGoogle Scholar
• Seliem RM, Griffith RC, Harris NL, HHV-8+, EBV+ multicentric plasmablastic microlymphoma in an HIV+ Man: the spectrum of HHV-8+ lymphoproliferative disorders expands. Am J Surg Pathol 2007;31:1439–1445.
   PubMed Web of Science ®Google Scholar
• Re A, Facchetti F, Borlenghi E, Fatal hemophagocytic syndrome related to active human herpesvirus-8/Kaposi sarcoma-associated herpesvirus infection in human immunodeficiency virus-negative, non-transplant patients without related malignancies. Eur J Haematol 2007;78:361–364.
   PubMedGoogle Scholar
• Bhatia S, Bauer F, Bilgrami SA. Candidiasis-associated hemophagocytic lymphohistiocytosis in a patient infected with human immunodeficiency virus. Clin Infect Dis 2003;37:e161–e166.
   PubMed Web of Science ®Google Scholar
• Guillaume MP, Driessens N, Libert M, Hemophagocytic syndrome associated with extracerebral toxoplasmosis in an HIV-infected patient. Eur J Intern Med 2006;17:503–504.
   PubMedGoogle Scholar
• Grateau G, Bachmeyer C, Blanche P, Haemophagocytic syndrome in patients infected with the human immunodeficiency virus: nine cases and a review. J Infect 1997;34:219–225.
   PubMed Web of Science ®Google Scholar
• Kessler HA, Bick JA, Pottage JC Jr, AIDS: Part II. Dis Mon 1992;38:691–764.
   PubMedGoogle Scholar
• Serrano-Villar S, Quereda C, Moreno A, Neutropenia during therapy with peginterferon and ribavirin in HIV-infected subjects with chronic hepatitis C and the risk of infections. Clin Infect Dis 2013;57:458–464.
   PubMedGoogle Scholar
• Mira JA, López-Cortés LF, Merino D, Predictors of severe haematological toxicity secondary to pegylated interferon plus ribavirin treatment in HIV-HCV-coinfected patients. Antivir Ther 2007;12:1225–1235.
   PubMed Web of Science ®Google Scholar
• Lefevre F, O'Leary B, Moran M, Alcohol consumption among HIV-infected patients. J Gen Intern Med 1995;10:458–460.
   PubMed Web of Science ®Google Scholar
• Miguez MJ, Shor-Posner G, Morales G, HIV treatment in drug abusers: impact of alcohol use. Addict Biol 2003;8:33–37.
   PubMed Web of Science ®Google Scholar
• Justice AC, Lasky E, McGinnis KA, Medical disease and alcohol use among veterans with human immunodeficiency infection: A comparison of disease measurement strategies. Med Care 2006;44:S52–S60.
   PubMed Web of Science ®Google Scholar
• Conigliaro J, Gordon AJ, McGinnis KA, How harmful is hazardous alcohol use and abuse in HIV infection: do health care providers know who is at risk? J Acquir Immune Defic Syndr 2003;33:521–525.
   PubMed Web of Science ®Google Scholar
• Bagasra O, Kajdacsy-Balla A, Lischner HW, Alcohol intake increases human immunodeficiency virus type 1 replication in human peripheral blood mononuclear cells. J Infect Dis 1993;167:789–797.
   PubMed Web of Science ®Google Scholar
• Bagasra O, Bachman SE, Jew L, Increased human immunodeficiency virus type 1 replication in human peripheral blood mononuclear cells induced by ethanol: potential immunopathogenic mechanisms. J Infect Dis 1996;173:550–558.
   PubMed Web of Science ®Google Scholar
• Bagby GJ, Stoltz DA, Zhang P, The effect of chronic binge ethanol consumption on the primary stage of SIV infection in rhesus macaques. Alcohol Clin Exp Res 2003;27:495–502.
   Google Scholar
• Bagby GJ, Zhang P, Purcell JE, Chronic binge ethanol consumption accelerates progression of simian immunodeficiency virus disease. Alcohol Clin Exp Res 2006;30:1781–1790.
   PubMed Web of Science ®Google Scholar
• Poonia B, Nelson S, Bagby GJ, Chronic alcohol consumption results in higher simian immunodeficiency virus replication in mucosally inoculated rhesus macaques. AIDS Res Hum Retroviruses 2006;22:589–594.
   PubMedGoogle Scholar
• Nelson S, Happel KI, Zhang P, Effect of bacterial pneumonia on lung simian immunodeficiency virus (SIV) replication in alcohol consuming SIV-infected rhesus macaques. Alcohol Clin Exp Res 2013;37:969–977.
   PubMedGoogle Scholar
• Kumar R, Perez-Casanova AE, Tirado G, Increased viral replication in simian immunodeficiency virus/simian-HIV-infected macaques with self-administering model of chronic alcohol consumption. J Acquir Immune Defic Syndr 2005;39:386–390.
   PubMed Web of Science ®Google Scholar
• Samet JH, Cheng DM, Libman H, Alcohol consumption and HIV disease progression. J Acquir Immune defic Syndr 2007;46:194–199.
   PubMed Web of Science ®Google Scholar
• Samet JH, Horton NJ, Traphagen ET, Alcohol consumption and HIV disease progression: are they related? Alcohol Clin Exp Res 2003;27:862–867.
   PubMed Web of Science ®Google Scholar
• Fong IW, Read S, Wainberg MA, Alcoholism and rapid progression to AIDS after seroconversion. Clin Infect Dis 1994;19:337–338.
   PubMed Web of Science ®Google Scholar
• Balla AK, Lischner HW, Pomerantz RJ, Human studies on alcohol and susceptibility to HIV infection. Alcohol 1994;11:99–103.
   PubMed Web of Science ®Google Scholar
• Ballard HS. Alcohol-associated pancytopenia with hypocellular bone marrow. Am J Clin Pathol 1980;73:830–834.
   PubMedGoogle Scholar
• Ballard HS. Hematological complications of alcoholism. Alcohol Clin Exp Res 1989;13:706–720.
   PubMed Web of Science ®Google Scholar
• Heermans EH. Booze and blood: the effects of acute and chronic alcohol abuse on the hematopoietic system. Clin Lab Sci 1998;11:229–232.
   PubMedGoogle Scholar
• Liu YK. Effects of alcohol on granulocytes and lymphocytes. Semin Hematol 1980;17:130–136.
   PubMed Web of Science ®Google Scholar
• Michot F, Gut J. Alcohol-induced bone marrow damage. A bone marrow study in alcohol-dependent individuals. Acta Haematol 1987;78:252–257.
   PubMedGoogle Scholar
• Imperia PS, Chikkappa G, Phillips PG. Mechanism of inhibition of granulopoiesis by ethanol. Proc Soc Exp Biol Med Soc 1984;175:219–225.
   PubMedGoogle Scholar
• Nakao S, Harada M, Kondo K, Reversible bone marrow hypoplasia induced by alcohol. Am J Hematol 1991;37:120–123.
   PubMedGoogle Scholar
• Yeung KY, Klug PP, Lessin LS. Alcohol-induced vacuolization in bone marrow cells: ultrastructure and mechanism of formation. Blood Cells 1988;13:487–502.
   PubMedGoogle Scholar
• Tisman G, Herbert V. In vitro myelosuppression and immunosuppression by ethanol. J Clin Invest 1973;52:1410–1414.
   PubMedGoogle Scholar
• Zhang P, Welsh DA, Siggins RW 2nd, Acute alcohol intoxication inhibits the lineage- c-kit +Sca-1+ cell response to Escherichia coli bacteremia. J Immunol 2009;182:1568–1576.
   PubMedGoogle Scholar
• Melvan JN, Siggins RW, Bagby GJ, Suppression of the stem cell antigen-1 response and granulocyte lineage expansion by alcohol during septicemia. Crit Care Med 2011;39:2121–2130.
   PubMed Web of Science ®Google Scholar
• Siggins RW, Melvan JN, Welsh DA, Alcohol suppresses the granulopoietic response to pulmonary Streptococcus pneumoniae infection with enhancement of STAT3 signaling. J Immunol 2011;186:4306–4313.
   PubMedGoogle Scholar
• Raasch CE, Zhang P, Siggins RW 2nd, Acute alcohol intoxication impairs the hematopoietic precursor cell response to pneumococcal pneumonia. Alcohol Clin Exp Res 2010;34:2035–2043.
   PubMedGoogle Scholar
• Sampson M, Zhu QS, Corey SJ. Src kinases in G-CSF receptor signaling. Front Biosci 2007;12:1463–1474.
   PubMed Web of Science ®Google Scholar
• Melvan JN, Siggins RW, Stanford WL, Alcohol impairs the myeloid proliferative response to bacteremia in mice by inhibiting the stem cell antigen-1/ERK pathway. J Immunol 2012;188:1961–1969.
   PubMedGoogle Scholar
• Singh AK, Jiang Y, Gupta S. Effects of chronic alcohol drinking on receptor-binding, internalization, and degradation of human immunodeficiency virus 1 envelope protein gp120 in hepatocytes. Alcohol 2007;41:591–606.
   PubMed Web of Science ®Google Scholar
• Prakash O, Rodriguez VE, Tang ZY, Inhibition of hematopoietic progenitor cell proliferation by ethanol in human immunodeficiency virus type 1 tat-expressing transgenic mice. Alcohol Clin Exp Res 2001;25:450–456.
   PubMed Web of Science ®Google Scholar
• Wang Y, Li Y, Mao K, Alcohol-induced adipogenesis in bone and marrow: a possible mechanism for osteonecrosis. Clin Orthop Relat Res 2003;213–224.
   PubMedGoogle Scholar
• Wezeman FH, Gong Z. Bone marrow triglyceride accumulation and hormonal changes during long-term alcohol intake in male and female rats. Alcohol Clin Exp Res 2001;25:1515–1522.
   PubMedGoogle Scholar
• Wezeman FH, Gong Z. Adipogenic effect of alcohol on human bone marrow-derived mesenchymal stem cells. Alcohol Clin Exp Res 2004;28:1091–1101.
   PubMed Web of Science ®Google Scholar
• Wickramasinghe SN, Hasan R. Possible role of macrophages in the pathogenesis of ethanol-induced bone marrow damage. Br J Haematol 1993;83:574–579.
   PubMedGoogle Scholar
• Cui Q, Wang Y, Saleh KJ, Alcohol-induced adipogenesis in a cloned bone-marrow stem cell. J bone Joint Surg AM 2006;88(Suppl 3):148–154.
   PubMedGoogle Scholar
• Gong Z, Wezeman FH. Inhibitory effect of alcohol on osteogenic differentiation in human bone marrow-derived mesenchymal stem cells. Alcohol Clin Exp Res 2004;28:468–479.
   PubMed Web of Science ®Google Scholar
• Suh KT, Kim SW, Roh HL, Decreased osteogenic differentiation of mesenchymal stem cells in alcohol-induced osteonecrosis. Clin Orthop Related Res 2005;220–225.
   PubMedGoogle Scholar
• Morad V, Pevsner-Fischer M, Barnees S, The myelopoietic supportive capacity of mesenchymal stromal cells is uncoupled from multipotency and is influenced by lineage determination and interference with glycosylation. Stem Cells 2008;26:2275–2286.
   PubMed Web of Science ®Google Scholar
• MacGregor RR, Louria DB. Alcohol and infection. Curr Clin Top Infect Dis 1997;17:291–315.
   PubMedGoogle Scholar
• Zhang P, Summer WR, Bagby GJ, Innate immunity and pulmonary host defense. Immunol Rev 2000;173:39–51.
   PubMed Web of Science ®Google Scholar
• Zhang P, Bagby GJ, Happel KI, Alcohol abuse, immunosuppression, and pulmonary infection. Curr Drug Abuse Rev 2008;1:56–67.
   PubMedGoogle Scholar
• Zhang P, Bagby GJ, Happel KI, Pulmonary host defenses and alcohol. Front Biosci 2002;7:d1314–d1330.
   PubMed Web of Science ®Google Scholar
• Wang X, Ho WZ. Drugs of abuse and HIV infection/replication: implications for mother-fetus transmission. Life Sci. 2011;88:972–979.
   PubMedGoogle Scholar
• Kapadia F, Vlahov D, Donahoe RM, The role of substance abuse in HIV disease progression: reconciling differences from laboratory and epidemiologic investigations. Clin Infect Dis 2005;41:1027–1034.
   PubMed Web of Science ®Google Scholar
• Celentano DD, Galai N, Sethi AK, Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users. AIDS 2001;15:1707–1715.
   PubMed Web of Science ®Google Scholar
• Ding L, Landon BE, Wilson IB, Predictors and consequences of negative physician attitudes toward HIV-infected injection drug users. Arch Intern Med 2005;165:618–623.
   PubMed Web of Science ®Google Scholar
• Firnhaber C, Smeaton L, Saukila N, Comparisons of anemia, thrombocytopenia, and neutropenia at initiation of HIV antiretroviral therapy in Africa, Asia, and the Americas. Int J Infect Dis 2010;14:e1088–e1092.
   PubMed Web of Science ®Google Scholar
• Coyle TE. Hematologic complications of human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Med Clin North Am 1997;81:449–470.
   PubMed Web of Science ®Google Scholar
• Dybul M, Fauci AS, Bartlett JG, Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Ann Intern Med 2002;137:381–433.
   PubMed Web of Science ®Google Scholar
• Sterne JA, May M, Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet 2009;373:1352–1363.
   PubMed Web of Science ®Google Scholar
• Choi SY, Kim I, Kim NJ, Hematological manifestations of human immunodeficiency virus infection and the effect of highly active anti-retroviral therapy on cytopenia. Korean J Hematol 2011;46:253–257.
   PubMedGoogle Scholar
• Moyle G, Sawyer W, Law M, Changes in hematologic parameters and efficacy of thymidine analogue-based, highly active antiretroviral therapy: a meta-analysis of six prospective, randomized, comparative studies. Clin Ther 2004;26:92–97.
   PubMed Web of Science ®Google Scholar
• Frumkin LR. Role of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the treatment of patients with HIV infection. Curr Opin Hematol 1997;4:200–206.
   PubMedGoogle Scholar
• Hermans P, Rozenbaum W, Jou A, Filgrastim to treat neutropenia and support myelosuppressive medication dosing in HIV infection. G-CSF 92105 Study Group. AIDS 1996;10:1627–1633.
   PubMedGoogle Scholar
• Kuritzkes DR, Parenti D, Ward DJ, Filgrastim prevents severe neutropenia and reduces infective morbidity in patients with advanced HIV infection: results of a randomized, multicenter, controlled trial. G-CSF 930101 Study Group. AIDS 1998;12:65–74.
   PubMedGoogle Scholar
• Keiser P, Rademacher S, Smith JW, Granulocyte colony-stimulating factor use is associated with decreased bacteremia and increased survival in neutropenic HIV-infected patients. Am J Med 1998;104:48–55.
   PubMedGoogle Scholar
• Motabi IH, DiPersio JF. Advances in stem cell mobilization. Blood Rev 2012;26:267–278.
   PubMedGoogle Scholar
• Pelus LM, Fukuda S. Chemokine-mobilized adult stem cells;defining a better hematopoietic graft. Leukemia 2008;22:466–473.
   PubMed Web of Science ®Google Scholar
• Nielsen SD, Sørensen TU, Aladdin H, The effect of long-term treatment with granulocyte colony-stimulating factor on hematopoiesis in HIV-infected individuals. Scand J Immunol 2000;52:298–303.
   PubMed Web of Science ®Google Scholar
• Barbaro G, Di Lorenzo G, Grisorio B, Effect of recombinant human granulocyte-macrophage colony-stimulating factor on HIV-related leukopenia: a randomized, controlled clinical study. AIDS 1997;11:1453–1461.
   PubMed Web of Science ®Google Scholar
• Angel JB, High K, Rhame F, Phase III study of granulocyte-macrophage colony-stimulating factor in advanced HIV disease: effect on infections, CD4 cell counts and HIV suppression. Leukine/HIV Study Group. AIDS 2000;14:387–395.
   PubMed Web of Science ®Google Scholar
• McClure J, van't Wout AB, Tran T, Granulocyte-monocyte colony-stimulating factor upregulates HIV-1 replication in monocyte-derived macrophages cultured at low density. J Acquir Immune Defic Syndr 2007;44:254–261.
   PubMedGoogle Scholar
• Kandanearatchi A, Zuckerman M, Smith M, Granulocyte-macrophage colony-stimulating factor enhances viral load in human brain tissue: amelioration with stavudine. AIDS 2002;16:413–420.
   PubMedGoogle Scholar
• Jacobson JM, Lederman MM, Spritzler J, Granulocyte-macrophage colony-stimulating factor induces modest increases in plasma human immunodeficiency virus (HIV) type 1 RNA levels and CD4+ lymphocyte counts in patients with uncontrolled HIV infection. J Infect Dis 2003;188:1804–1814.
   PubMed Web of Science ®Google Scholar
• Scadden DT, Pickus O, Hammer SM, Lack of in vivo effect of granulocyte-macrophage colony-stimulating factor on human immunodeficiency virus type 1. AIDS Res Hum Retroviruses 1996;12:1151–1159.
   PubMed Web of Science ®Google Scholar
• Kedzierska K, Maerz A, Warby T, Granulocyte-macrophage colony-stimulating factor inhibits HIV-1 replication in monocyte-derived macrophages. AIDS 2000;14:1739–1748.
   PubMedGoogle Scholar
• Fagard C, Le Braz M, Günthard H, A controlled trial of granulocyte macrophage-colony stimulating factor during interruption of HAART. AIDS 2003;17:1487–1492.
   PubMed Web of Science ®Google Scholar
• Hoffman R, Tong J, Brandt J, The in vitro and in vivo effects of stem cell factor on human hematopoiesis. Stem Cells 1993;11(Suppl 2):76–82.
   PubMedGoogle Scholar
• McNiece IK, Briddell RA. Stem cell factor. J Leukoc Biol 1995;58:14–22.
   PubMed Web of Science ®Google Scholar
• Barreda DR, Hanington PC, Belosevic M. Regulation of myeloid development and function by colony stimulating factors. Dev Comp Immunol 2004;28:509–554.
   PubMed Web of Science ®Google Scholar
• Ihle JN. Interleukin-3 and hematopoiesis. Chem Immunol 1992;51:65–106.
   PubMed Web of Science ®Google Scholar
• Bucur SZ, Lackey DA 3rd, Adams JW, Hematologic and virologic effects of lineage-specific and non-lineage-specific recombinant human and rhesus cytokines in a cohort of SIVmac239-infected macaques. AIDS Res Hum Retroviruses 1998;14:651–660.
   PubMedGoogle Scholar
• Baltimore D. Gene therapy. Intracellular immunization. Nature 1988;335:395–396.
   PubMed Web of Science ®Google Scholar
• Kiem HP, Jerome KR, Deeks SG, Hematopoietic-stem-cell-based gene therapy for HIV disease. Cell Stem Cell 2012;10:137–147.
   PubMed Web of Science ®Google Scholar
• Hoxie JA, June CH. Novel cell and gene therapies for HIV. Cold Spring Harb Perspect Med 2012;2:1–21.
   Google Scholar
• Hütter G, Nowak D, Mossner M, Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. N Engl J Med 2009;360:692–698.
   PubMed Web of Science ®Google Scholar
• Lai Y. CCR5-targeted hematopoietic stem cell gene approaches for HIV disease: current progress and future prospects. Curr Stem Cell Res Ther 2012;7:310–317.
   PubMedGoogle Scholar
• Rossi JJ, June CH, Kohn DB. Genetic therapies against HIV. Nat Biotechnol 2007;25:1444–1454.
   PubMed Web of Science ®Google Scholar